Find News

Filter articles

Applied Filters

Showing 791 to 800 of 807 results

US appeals court refuses Arzerra rehearing


Biotechnology company Genmab A/S announced on July 15 that the US Court of Appeals for the Federal Circuit has refused a request to rehear a case related to its Arzerra product.

IPAB rejects Monsanto plant patent


India’s Intellectual Property Appellate Board has affirmed that US agricultural company Monsanto cannot obtain a patent covering transgenic plants, two years after it was first rejected.

Novartis strikes vaccine licensing deal with Indian biopharma


Novartis has signed a development and licensing agreement with Indian biopharmaceutical company Biological E Limited (BioE) to deliver two vaccines that protect against typhoid and paratyphoid fevers.

US Supreme Court strikes Myriad blow


The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.

Patents covering IVF test spark row


Members of the scientific community have blasted Stanford University and US biotechnology company Auxogyn for their involvement in patenting a test designed to increase the success of in vitro fertilisation (IVF).

Hi-tech and life sciences dominate at EPO awards


The inventor of the world’s first flat-panel liquid crystal display, Martin Schadt, was among a number of winners at the European Patent Office European Inventor Award 2013.

WHO issues IP warning over MERS virus


The World Health Organization has warned that “no IP will stand in the way of public health actions” amid the spreading of a deadly global virus.

RuiYi joins with Genor to develop cancer treatment

China, US20-05-2013

San Diego-Shanghai biotechnology startup RuiYi Inc has entered into an exclusive license and collaborative development agreement with Shanghai-based Genor BioPharma to develop the RYI-008 molecule in China.

Ideas Matter: the importance of IP in the fight against cancer


On May 14, healthcare experts met in London to share and discuss developments in cancer detection, prevention, treatment and maintenance, and how IP protection and management are vital in attracting investment.

Ideas Matter: Philips and Microsoft in life sciences


At the Ideas Matter roundtable last week LSIPR spoke to Maaike van Velzen, general manager of Philips Group Innovation’s IP and Standards division, about the importance of using IP to promote the company’s vision.

Showing 791 to 800 of 807 results